Story perspectives

Weill Cornell Secures $3.4M Grant to Combat Type 1 Diabetes

9/13/2025

50 4

Summary

Story summary

Weill Cornell Medicine secured a $3.4 million NIH grant to study type 1 diabetes.
Dr. Shuibing Chen leads the project, examining autoimmune mechanisms impacting insulin-producing beta cells.
The research targets genetic and environmental factors using organoid models and computational tools.
Investigators will map genetic variants that affect immune tolerance and beta cell resilience.
The study aims to identify early molecular markers for improved diagnosis and intervention.

1 of 1

Story summary

Weill Cornell Medicine secured a $3.4 million NIH grant to study type 1 diabetes.
Dr. Shuibing Chen leads the project, examining autoimmune mechanisms impacting insulin-producing beta cells.
The research targets genetic and environmental factors using organoid models and computational tools.
Investigators will map genetic variants that affect immune tolerance and beta cell resilience.
The study aims to identify early molecular markers for improved diagnosis and intervention.